{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:55:33Z","timestamp":1761562533955,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008978","name":"Philips Oral Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.carrev.2019.05.010","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T19:55:29Z","timestamp":1557777329000},"page":"622-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expanding the Treatment of Calcified Lesions"],"prefix":"10.1016","volume":"20","author":[{"given":"Nauman","family":"Khalid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toby","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Shlofmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuefeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2019.05.010_bb0005","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.carrev.2019.04.020","article-title":"Letter by Bilazarian et al. regarding the article, \u201cAdverse events and modes of failure related to Impella RP: insights from the Manufacturer and User Facility Device Experience (MAUDE) database\u201d by Khalid et al","volume":"20","author":"Bilazarian","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2019.05.010_bb0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.carrev.2019.03.010","article-title":"Adverse events and modes of failure related to Impella RP: insights from the Manufacturer and User Facility Device Experience (MAUDE) database","volume":"20","author":"Khalid","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2019.05.010_bb0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.carrev.2016.06.002","article-title":"Review: stent fracture in the drug-eluting stent era","volume":"17","author":"Omar","year":"2016","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2019.05.010_bb0030","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jvir.2014.04.016","article-title":"Comparison of complication rates associated with permanent and retrievable inferior vena cava filters: a review of the MAUDE database","volume":"25","author":"Andreoli","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.carrev.2019.05.010_bb0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/24748706.2017.1366086","article-title":"Clinical or symptomatic leaflet thrombosis following transcatheter aortic valve replacement: insights from the U.S. FDA MAUDE database","volume":"1","author":"Hafiz","year":"2017","journal-title":"Struct Heart"},{"key":"10.1016\/j.carrev.2019.05.010_bb0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.carrev.2019.02.016","article-title":"Adverse events associated with the use of guide extension catheters during percutaneous coronary intervention: reports from the Manufacturer and User Facility Device Experience (MAUDE) database","volume":"20","author":"Chen","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2019.05.010_bb0045","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-18-01021","article-title":"Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: a retrospective analysis of the MAUDE database","author":"Khalid","year":"2019","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2019.05.010_bb0050","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-19-00279R","article-title":"Reply to Chhabra et al, \u201cImpella device use in high-risk PCI\u201d","author":"Khalid","year":"2019","journal-title":"Eurointervention"},{"author":"Impella RP\u00ae Heart Pump Bulletin","key":"10.1016\/j.carrev.2019.05.010_bb0060"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919303094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919303094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:15:50Z","timestamp":1761560150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919303094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1553838919303094"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.05.010","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the Treatment of Calcified Lesions","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}